Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3 beta signaling pathway

Background Diabetic encephalopathy is manifested by cognitive dysfunction. Salidroside, a nature compound isolated from Rhodiola rosea L, has the effects of anti-inflammatory and antioxidant, hypoglycemic and lipid-lowering, improving insulin resistance, inhibiting cell apoptosis, and protecting neurons. However, the mechanism by which salidroside alleviates neuronal degeneration and improves learning and memory impairment in diabetic mice remains unclear. Objective To investigate the effects and mechanisms of salidroside on hippocampal neurons in streptozotocin-induced diabetic mice. Materials and methods C57BL/6 mice were randomly divided into 4 groups to receive either sham (control group (CON)), diabetes mellitus (diabetes group (DM)), diabetes mellitus + salidroside (salidroside group (DM + SAL)), and diabetes mellitus + salidroside + phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 (diabetes mellitus + salidroside + LY294002 group (DM + SAL + LY294002)). After 12 weeks of diabetes onset, the cognitive behaviors were tested using Morris water maze. The number of hippocampal neurons was detected by Nissl staining. The expressions of PI3K, p- PI3K, Akt, p-Akt, GSK-3 beta, p-GSK-3 beta, cleaved caspase-3, caspase-3, Bax, Bcl-2, MAP2, and SYN in the hippocampus were detected by Western blot. Moreover, the expression of MAP2 and SYN in the hippocampus was further confirmed by immunofluorescence staining. Results Salidroside increased the time of diabetic mice in the platform quadrant and reduced the escape latency of diabetic mice. Salidroside also increased the expression of p-PI3K, p-Akt, p-GSK-3 beta, MAP2, SYN, Bcl- 2, while suppressed the expression of cleaved caspase-3, caspase3, and Bax in the DM + SAL group compared with the DM group (P < 0.05). The Nissl staining showed that the number of hippocampus neurons in the DM + SAL group was increased with the intact, compact, and regular arrangement, compared with the DM groups (P < 0.05). Interestingly, the protective effects of salidroside on diabetic cognitive dysfunction, hippocampal morphological alterations, and protein expressions were abolished by inhibition of PI3K with LY294002. Conclusions Salidroside exerts neuroprotective properties in diabetic cognitive dysfunction partly via activating the PI3K/ Akt/GSK-3 beta signaling pathway.

Automated summary

The study aimed to investigate the effects and mechanisms of salidroside on hippocampal neurons in streptozotocin-induced diabetic mice. The results showed that salidroside could improve cognitive function, increase the number of hippocampal neurons, and promote the activation of the PI3K/Akt/GSK-3 beta signaling pathway in diabetic mice. This study revealed a partial mechanism by which salidroside exerts neuroprotective effects in diabetic cognitive dysfunction.